Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron versus metoclopramide for prevention of nausea and vomiting after cesarean section
IRCT20170502033762N2Phase 3Completed
- Sponsor
- Zabol University of Medical Sciences
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in postoperative nausea and vomiting (PONV) comparing Ondansetron with Metoclopramide (2 arms). Primary endpoint: Nausea and vomiting after cesarean section. Started May 2016; status: completed.
02
Drugs
ondansetronmetoclopramide
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20170502033762N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170502033762N2.